• SOPHiA GENETICS SA does IPO on Nasdaq

    On 22 July 2021, SOPHiA GENETICS SA, a Swiss healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research, priced its USD 234 million IPO, consisting of an offering of 13,000,000 ordinary shares at a price of USD 18.00 per share. The ordinary shares…


    Read more: SOPHiA GENETICS SA does IPO on Nasdaq